← FDA Drug Approvals (Drugs@FDA)
CLOMIPHENE CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON · Approved 2024-11-12
Drug application
- FDA Application #
ANDA216545- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOMIPHENE CITRATE
- Generic name
- CLOMIPHENE CITRATE
- Active ingredients
- CLOMIPHENE CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2024-11-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown